Curran Simpson, Regenxbio CEO
Regenxbio shares first data showing Duchenne gene therapy improves muscle function
Regenxbio said its gene therapy improved muscle function in a handful of boys with Duchenne muscular dystrophy across two doses.
The gene therapy company said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.